Skip to content

Organigram CEO Greg Engel steps down, Peter Amirault appointed on interim basis


MONCTON, N.B. — Organigram Holdings Inc. says Greg Engel is stepping down from his chief executive post.

The Moncton, N.B.-based cannabis company did not offer details on Engel's departure, but says he will continue to act as a special adviser to the board during a "transition period.

Organigram's board chairman Peter Amirault has been appointed to serve as executive chair on an interim basis and oversee day-to-day management of the company until a new CEO is named.

Engel has led the company since 2017 and was recently involved with signing Organigram's $221-million deal with British American Tobacco.

In the months leading up to the deal, Organigram announced it would cultivate less cannabis than its Moncton facilities were designed to produce.

It also laid off at least 220 workers, or roughly one-quarter of its staff.

This report by The Canadian Press was first published May 3, 2021.

Companies in this story: (TSX:OGI)

The Canadian Press